Literature DB >> 12526705

Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.

Supriya Shukla1, Gong Wu, Madhumita Chatterjee, Weilian Yang, Masaru Sekido, Lamine A Diop, Rainer Müller, Jennifer J Sudimack, Robert J Lee, Rolf F Barth, Werner Tjarks.   

Abstract

Successful treatment of cancer by boron neutron capture therapy (BNCT) requires the selective delivery of (10)B to constituent cells within a tumor. The expression of the folate receptor is amplified in a variety of human tumors and potentially might serve as a molecular target for BNCT. In the present study we have investigated the possibility of targeting the folate receptor on cancer cells using folic acid conjugates of boronated poly(ethylene glycol) (PEG) containing 3rd generation polyamidoamine dendrimers to obtain (10)B concentrations necessary for BNCT by reducing the uptake of these conjugates by the reticuloendothelial system. First we covalently attached 12-15 decaborate clusters to 3rd generation polyamidoamine dendrimers. Varying quantities of PEG units with varying chain lengths were then linked to these boronated dendrimers to reduce hepatic uptake. Among all prepared combinations, boronated dendrimers with 1-1.5 PEG(2000) units exhibited the lowest hepatic uptake in C57BL/6 mice (7.2-7.7% injected dose (ID)/g liver). Thus, two folate receptor-targeted boronated 3rd generation polyamidoamine dendrimers were prepared, one containing approximately 15 decaborate clusters and approximately 1 PEG(2000) unit with folic acid attached to the distal end, the other containing approximately 13 decaborate clusters, approximately 1 PEG(2000) unit, and approximately 1 PEG(800) unit with folic acid attached to the distal end. In vitro studies using folate receptor (+) KB cells demonstrated receptor-dependent uptake of the latter conjugate. Biodistribution studies with this conjugate in C57BL/6 mice bearing folate receptor (+) murine 24JK-FBP sarcomas resulted in selective tumor uptake (6.0% ID/g tumor), but also high hepatic (38.8% ID/g) and renal (62.8% ID/g) uptake, indicating that attachment of a second PEG unit and/or folic acid may adversely affect the pharmacodynamics of this conjugate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526705     DOI: 10.1021/bc025586o

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  19 in total

Review 1.  Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.

Authors:  Wassana Wijagkanalan; Shigeru Kawakami; Mitsuru Hashida
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Authors:  Douglas G Mullen; Daniel Q McNerny; Ankur Desai; Xue-Min Cheng; Stassi C Dimaggio; Alina Kotlyar; Yueyang Zhong; Suyang Qin; Christopher V Kelly; Thommey P Thomas; Istvan Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2011-03-22       Impact factor: 4.774

3.  Synthesis of Closo-1,7-Carboranyl Alkyl Amines.

Authors:  Hitesh K Agarwal; Benjamin Buszek; Kevin G Ricks; Werner Tjarks
Journal:  Tetrahedron Lett       Date:  2011-10-26       Impact factor: 2.415

4.  Nanotechnology of emerging targeting systems.

Authors:  S S Smith
Journal:  Minerva Biotecnol       Date:  2008-09       Impact factor: 3.028

Review 5.  Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.

Authors:  Bagher Farhood; Hadi Samadian; Mahdi Ghorbani; Seyed Salman Zakariaee; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-01

6.  Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.

Authors:  Douglas G Mullen; Emilee L Borgmeier; Ming Fang; Daniel Q McNerny; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Macromolecules       Date:  2010-08-24       Impact factor: 5.985

7.  3H dendrimer nanoparticle organ/tumor distribution.

Authors:  Shraddha S Nigavekar; Lok Yun Sung; Mikel Llanes; Areej El-Jawahri; Theodore S Lawrence; Christopher W Becker; Lajos Balogh; Mohamed K Khan
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 8.  Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.

Authors:  Gann Ting; Chih-Hsien Chang; Hsin-Ell Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2010-08-03

9.  Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.

Authors:  Yoonkyung Kim; Athena M Klutz; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2008-07-09       Impact factor: 4.774

10.  Folate-mediated Cell Uptake of Shell-crosslinked Spheres and Cylinders.

Authors:  Ke Zhang; Raffaella Rossin; Aviv Hagooly; Zhiyun Chen; Michael J Welch; Karen L Wooley
Journal:  J Polym Sci A Polym Chem       Date:  2008       Impact factor: 2.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.